Has participated in:
-
Promise and challenges of clinical non-invasive T-cell tracking in the era of cancer immunotherapy
-
High-resolution profile of neoantigen-specific TCR activation links moderate stimulation to increased resilience of engineered TCR-T cells
-
In vitro and in vivo characterization of T-cell receptors specifically recognizing human melanoma neoantigens identified by immunopeptidomics and in-silico predictions
-
Identification of neoantigen-specific T-cell responses in diverse rare tumor entities